Vascular Endothelial Growth Factor Antagonists And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonists And Methods For Their Use US Patent 9,550,818Filed on 2014-10-27
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use European Patent13720737.9Filed on 2013-04-26
Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Read more about Vascular Endothelial Growth Factor Antagonist And Methods For Their Use Canada2870769Filed on 2013-04-26
VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS AND METHODS FOR THEIR USE Read more about VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS AND METHODS FOR THEIR USE Australia2013251375Filed on 2013-04-26
Anti-Mesothelin Chimeric Antigen Receptors Read more about Anti-Mesothelin Chimeric Antigen Receptors US Patent 9,359,447Filed on 2014-09-10
Anti-Mesothelin Chimeric Antigen Receptors Read more about Anti-Mesothelin Chimeric Antigen Receptors European Patent13717593.1Filed on 2013-03-05
Anti-Mesothelin Chimeric Antigen Receptors Read more about Anti-Mesothelin Chimeric Antigen Receptors Canada2868121Filed on 2013-03-05
Anti-Mesothelin Chimeric Antigen Receptors Read more about Anti-Mesothelin Chimeric Antigen Receptors Australia2013235726Filed on 2013-03-05
CHALCONE DERIVATIVES AS NRF2 ACTIVATORS Read more about CHALCONE DERIVATIVES AS NRF2 ACTIVATORS US Application 14/000,816Filed on 2013-12-10
Engineered Antibody Constant Domain Molecules Read more about Engineered Antibody Constant Domain Molecules China201410422052.8Filed on 2009-01-30